Shenzhen Neptunus Interlong Bio-Tech News and Activities
Presence
Shenzhen Neptunus Interlong Bio-Tech develops and manufactures pharmaceutical products and health medicines. Its products serve hospitals, pharmacies, distributors, and patients in China through prescription, over the counter, and healthcare markets.
Shenzhen Neptunus Interlong Bio-Tech products and services overview:
- Prescription drugs
- OTC medicines
- Biologic medicines
- Health supplements
- Medical injections
Revenue: ~$300 million
Employees: 2,500
Headquarters: Shenzhen, China
Shenzhen Neptunus Interlong Bio-Tech is one of the...
Shenzhen Neptunus Interlong Bio-Tech is a company listed under the stock ticker 000078 (CN).
Executives
View the org chart displaying its 13 main executives
Most searched biographies at Shenzhen Neptunus Interlong Bio-Tech
- Feng Zhang, Executive Chairman of the Board and Compliance Officer
- Yifei Zhang, Non-Executive Director
- Rui Jin, Non-Executive Director
Create your alert
to follow the executive moves at Shenzhen Neptunus Interlong Bio-Tech.
Pharmaceuticals
Shenzhen Neptunus Interlong Bio-Tech has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Shenzhen Neptunus Interlong Bio-Tech
Social media about Shenzhen Neptunus Interlong Bio-Tech
- Shenzhen Neptunus Interlong Bio-Tech on Wikipedia, Google News & Yahoo Finance
- Shenzhen Neptunus Interlong Bio-Tech on LinkedIn, X (Twitter) & YouTube
